
ã¯ã¯ãã³ã«å¯Ÿãã瀟äŒçæ¯æãäœäžãããªããå¥åº·ã®èªç±ãæè·ãã人ã ã¯åäŸã®è§£æ¯ãå©ããæªæ¥ã«ç®ãåãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
æè¿ã®æ¿åºå ±åæžãäžè«èª¿æ»ã«ããã°ãã¯ã¯ãã³ã®åãå ¥ãæ å¢ã¯åŒ±ãŸãã€ã€ããããã¿ãã³ã®ç ãäœã«æªãããšã誰ããç¥ã£ãŠããã®ãšåãããã«ãã¯ã¯ãã³ã®åé¡ç¹ã誰ããç¥ããªããã°ãªããŸããããšçç©åŠè ã®ã¯ãªã¹ãã£ãŒãã»ããŒã¯ã¹å士ã¯èšãã
æè¿ã®æ¿åºå ±åæžãäžè«èª¿æ»ã«ããã°ãã¯ã¯ãã³ã®å容ãšéèŠã¯æžå°ããŠããã
ç±³çŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒã9æã«çºè¡šããå ±åæžã«ãããšã2020幎ãš2021幎çãŸãã®åã©ãã®ã¯ã¯ãã³æ¥çš®çã¯ã2018幎ãš2019幎çãŸãã®åã©ãã®æ¥çš®çãäžåã£ãããã®äœäžã¯ãã»ãŒãã¹ãŠã®ã¯ã¯ãã³ãã§èŠããã1.3ã7.8ãã€ã³ãã®å¹ ããã£ãã
å ±åæžã¯ãŸãããžãããªã¢ãç Žå·é¢šãçŸæ¥å³ïŒDTaP ïŒãšããªãªã®ã¯ã¯ãã³æ¥çš®çã«ã€ããŠãCDCã®95ïŒ ç®æšãéæããå·ã¯ããã12å·ã§ãã£ãããšã瀺ãããã¯ããããããµãããã颚ç¹ïŒMMRïŒã®å°å 2åæ¥çš®ã®95ïŒ ç®æšãéæããã®ã¯11å·ã®ã¿ã§ãã£ãã
æäººã®ã¯ã¯ãã³éèŠãæžå°ããŠãããCDCã®è¿œè·¡ããŒã¿ã«ãããšã10æ19æ¥çŸåšãCOVID-19ã¯ã¯ãã³ã®ä»å¹Žã®è£œå€ãæ¥çš®ããæäººã¯ããã13.5ïŒ ã§ã2022幎10æã«ã¯17ïŒ ã§ãã£ããCOVID-19ã¯ã¯ãã³ããå¿ ãæ¥çš®ããããšçããæäººã¯15.5ïŒ ã«éããªãã
ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®éèŠãäœäžããŠãããCDCã®ããŒã¿ãåŒçšããAxiosã®7æã®ã¬ããŒãã«ãããšããã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ã®éèŠã¯ããç¹ã«å»ççã«æãè匱ãªäžéšã®ã°ã«ãŒãã®éã§ ãæžå°ããŠããããšããã
ãã®ããŒã¿ã«ãããšã2023-2024幎ã®åŒåžåšç³»ãŠã€ã«ã¹ã·ãŒãºã³ã«ã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ãåãããšåçããæäººã®å²åã¯çŽ47ïŒ ã§ã2020-2021幎ã®50ïŒ ããæžå°ããŠããã
ã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ãåããé«éœ¢è ã®å²åã¯ã2020-2021幎ã®75ïŒ ããæžå°ãã2022-2023幎ã«ã¯70ïŒ ã§ãã£ããéå°å¹Žã§ã¯ã2023-2024幎ã®å²åã¯47ïŒ ã§ã2020-2021幎ã®56ïŒ ããæžå°ããåŠå©Šã§ã¯ãåæéã«53ïŒ ãã36ïŒ ã«æžå°ããã
Axiosã«ããã°ããã®æ°å㯠ããã³ãããã¯åŸã®äžçã§ã¯ã¯ã¯ãã³ã®äººæ°ãèœã¡ãŠããå¯èœæ§ããã ãããšã瀺åããŠããã
ã¯ã¯ãã³ã»ãªã¹ã¯ãæèããäžçãžã®æ©ã¿ãèŠããã
Defenderãèªã®åæã«å¿ããå¥åº·ã®èªç±ãæè·ãã人ã ã«ãšã£ãŠãã¯ã¯ãã³ã®ã人æ°å€±å¢ãã¯è¯ããã¥ãŒã¹ã§ããã
çç©åŠè ã®ã¯ãªã¹ãã£ãŒãã»ããŒã¯ã¹å士ã¯ããã®ãããªãã¥ãŒã¹ã«ã€ããŠããããããæœ®æã ããšèªã£ãã
ãã«ãã¬ã³ãºã»ãã«ã¹ã»ãã£ãã§ã³ã¹ã®äžçŽç ç©¶å¡ã§ããã«ãŒã«ã»ãžã£ããããŠã¹ããŒå士ã¯ãææ°ã®ããŒã¿ã瀺åããã®ã¯ããã¯ã¯ãã³ã»ãªã¹ã¯ãèªèããäžçã«åãã£ãŠåé²ããŠããããšããããšã§ããããšè¿°ã¹ããæš©åšãçããšãããåçŽã ãå±éºãªè¡çºãªãã«ã¯ããããªãããšã ããã ã
ç«åŠè ãã³ã©ã»ãã¥ã«ã·ã£ãŒã«ããã°ããç§ãã¡ã¯å€æ²ç¹ã«éãããäžç人å£ã®å€§éšåããåºç¯å²ã«åã¶èŠå¶ã®ææ¡ãšãéºäŒå泚å°ãããããç倧ãªå®³ãèªèããããã«ãªã£ãã
ã€ããããã¹ãã¯ãç§åŠçæç®ã¯ãŸã 人ã ã®æ 床ã®å€åã«è¿œãã€ããŠããªããšè¿°ã¹ãã圌ã¯ããä»ãå ããïŒ
ãç§åŠçèšèª¬ãèŒãæ©äŒãéããããšãåããŸããç§åŠéèªã¯ããŸã ã«ã¯ã¯ãã³ã®çãããã®ãªãå®å šæ§ãè³çŸããŠããããåœæ°æç¥šãäŒæ¥ã®å©æœ€è¿œæ±ã®å Žã§ã¯ã圌ãã¯ãã£ãšããç¥ã£ãŠãããå·æ¿åºã¯ãé£éŠæ¿åºãè¡ãããšããªãç ç©¶ãè¡ãããã«æ©ã¿å¯ã£ãŠããŸããã
ãã«ã·ã£ãŒã¯ãã¢ã€ããå·å西éšå°åºä¿å¥æããå»çãµãŒãã¹ãæäŸããŠãã30ã«æã§ã®COVID-19ã¯ã¯ãã³ã®æäŸãäžæ¢ããããšããäžè«ãå€ããã€ã€ããããäžã€ã®å åãšããŠææãããåå°åºã®è¡åã¯ããä»ã®çµç¹ã远éããããã®ã·ã°ãã«ãšãªãããšãæåŸ ããããšåœŒã¯è¿°ã¹ãã
å æãã¹ãããã¢æ¿åºã®å ¬åŒå ±åæžã¯ãmRNAã¯ã¯ãã³ã ãå±éº ãã§ãããšããåœå ã§ã®çŠæ¢ãæ±ããããŸãå æã«ã¯ã西ãªãŒã¹ãã©ãªã¢ã®çºã®è°äŒãããã¡ã€ã¶ãŒç€Ÿãšã¢ãã瀟ã®COVID-19ã¯ã¯ãã³ã®çŠæ¢ãæ±ããæ±ºè°æ¡ã坿±ºããã
ã¯ã¯ãã³ãšèªéçãšã®é¢é£æ§ãä¿¡ãã人ãå¢ããŠãããšã®èª¿æ»çµæ
ãªãã€ãªå·ç«å€§åŠãŠã§ã¯ã¹ããŒå»çã»ã³ã¿ãŒã9æã«å®æœãã調æ»ã«ãããšãCOVID-19ã®äºé²æ¥çš®ãåããäºå®ã®ããæäººã¯åæ°ä»¥äžã®43ïŒ ã§ã37ïŒ ã®åçè ã¯äºé²æ¥çš®ãåããå¿ èŠã¯ãªããšèããŠããããšãããã£ãã
7æã®ã®ã£ã©ããäžè«èª¿æ»ã«ãããšã調æ»å¯Ÿè±¡ã®æäººã®20ïŒ ããã¯ã¯ãã³ã¯å¯Ÿè±¡çŸæ£ãããå±éºããšåçããŠããã2019幎ã¯11ïŒ ã2001幎ã¯6ïŒ ã ã£ãã
å調æ»ã«ãããšãã¯ã¯ãã³ãšèªéçã«é¢é£æ§ããããšèããã¢ã¡ãªã«äººãå¢ããŠãããä»å¹Žã®æ°åã¯13ïŒ ã§ã2019幎ã®10ïŒ ã2015幎ã®6ïŒ ããäžæããŠãããèªéçã®åå ãšããŠã¯ã¯ãã³ãåŠå®ããã¢ã¡ãªã«äººã¯36ïŒ ã«éããªãã£ãã
æªæå¹Žã®èŠªã¯ããã¯ã¯ãã³ãèªéçã®åå ã§ãããšèããå²åããç±³åœã®æäººå šäœããããããã«é«ãã18ïŒ ã§ãã£ããããã¯ã¯ãã³ã¯èªéçã®åå ã§ã¯ãªãããšçãã芪ã¯29ïŒ ã«éããªãã£ãã芪ãåäŸã«ã¯ã¯ãã³ãæ¥çš®ããããšã¯ããŸã£ããéèŠã§ã¯ãªãããšçãã人ã®å²åã¯7ïŒ ã§ã2001幎ã®1ïŒ ããäžæããã
ã®ã£ã©ãã瀟ã®äžè«èª¿æ»ã«ããã°ãã¯ã¯ãã³æ¥çš®ã®çŸ©ååã«å¯Ÿããæ¯æçã51ïŒ ãšã2019幎ã®62ïŒ ã1991幎ã®81ïŒ ããäœäžããŠããã
å æã«ããã§å®æœããããªãµãŒãã³ã®èª¿æ»ã«ãããšãã«ãã人ã®29ïŒ ããåäŸã«äºé²æ¥çš®ãåãããããã©ããã¯èŠªããééããªãããŸãã¯ããããããæ±ºããã¹ãã ãšèããŠããã2022幎ãã9ãã€ã³ãäžæããã
ãŸããMMRã¯ã¯ãã³ãšèªéçãšã®éã«é¢é£æ§ããããšèããã«ãã人ã¯31ïŒ ã§ã2022幎ãã12ãã€ã³ãå¢å ããã
ã€ããŒã»ã©ã€ãã«ããã°ãããããã®æ°åã¯ãã¢ã¡ãªã«ã«ãããã¯ã¯ãã³ã«å¯Ÿããèãæ¹ã®å€åãšããããã倧ããªåŸåã瀺ããŠããããšããã
äŸãã°ããã€ã©ãŒå»ç§å€§åŠåœç«ç±åž¯å»åŠéšã®åŠé·ã§ããããããµã¹å°å ç é¢ã¯ã¯ãã³éçºã»ã³ã¿ãŒã®å ±åãã£ã¬ã¯ã¿ãŒã§ããããŒã¿ãŒã»ãããºå士ã¯ãã€ããŒã»ã©ã€ãã«å¯Ÿãããã¯ã¯ãã³å é€ãæ±ããèŠªãæ¥å¢ããŠããããšèªã£ãã
ããŒã¯ã¹æ°ã¯ãã¯ã¯ãã³ã«å¯Ÿããåœæ°ã®ä¿¡é Œã¯ ãå£ããŠããŸã£ã ããšããã人ã ã¯ä»ãå¥åº·ãå®ãå埩ãããæåã®æ¹æ³ã«ã€ããŠãåæ³çãªä»£æ¿æ å ±æºãæ±ããŠãã ããšè¿°ã¹ãã
ããŒã¯ã¹æ°ã¯ããã³ãããã¯ãšä¿å¥åœå±ãææãé²ãã¯ã¯ãã³ã ãšåããæ³šå°ã«ã€ããŠã人ã ã¯ãäœåºŠãäœåºŠãåãã€ãããããšã«æ°ã¥ããŠããããšè¿°ã¹ãã
ãCOVID-19ã®æ³šå°ã¯ïŒå®éšçãªéºäŒåæ²»çã®äžåœ¢æ ã§ãããææãé²ãããšã¯ã§ããã1åç®ã®æ³šå°åŸã®çç¶ã«å¯ŸããŠéåžžã«éå®çãªäºé²å¹æãããªãããšã«ã人ã ã¯åŸã«ãªã£ãŠæ°ã¥ããã®ã§ãããšããŒã¯ã¹æ°ã¯èªã£ãã
ããã°ã»ãã¡ãŒãã¯ããã¯ã¯ãã³ã¯å®å šã§ãã ããšããåãååã«ç¹°ãè¿ãã°ããããåŠå®ã§ããªãçå®ã«ãªããšããåæã§åããŠããã®ã§ãããããã©ããããCOVID-19ã¯ã¯ãã³ã®å±éºæ§ãæããã«ãªãã«ã€ãããå®å šã§å¹æç ããšããå®£äŒæå¥ã«ããããããããå¿ ç¶çã«åãšåã€ããæããã«ãªã£ã ãã®ã§ããã
ã¯ã¯ãã³ã¡ãŒã«ãŒãéèŠæžå°ã§å£²äžé«äºæ³ãäžæ¹ä¿®æ£
ã¯ã¯ãã³ã«å¯Ÿããåœæ°ã®ä¿¡é Œãäœäžããã«ã€ãã倧æè£œè¬äŒç€Ÿã¯ãã®åœ±é¿ãæã«æããŠããã
ä»é±åããGSKã¯RSVãšåž¯ç¶ç±ç¹äºé²æ³šå°ã®ãç±³åœã§ã®éèŠäœè¿·ã«ããã2024幎ã®ã¯ã¯ãã³å£²äžèŠéããäžæ¹ä¿®æ£ãããGSKã®ã¯ã¯ãã³å£²äžã¯åå¹Žåææ¯ã§18ïŒ æžå°ããã
å æãã¢ããã¯COVID-19ãšRSVã¯ã¯ãã³ã®2024幎売äžäºæž¬ã25ïŒ ãäžæ¹ä¿®æ£ããããã€ã¿ãŒéä¿¡ã«ãããšãããã¯ã2026幎ãŸã§ç¶ããšäºæ³ãããEUåãCOVIDã®å£²äžäœè¿·ããšãRSVäºé²æ¥çš®ã® ãäºæ³ä»¥äžã®é ãããã«ãããã®ã ãšããã
ä»é±åããã¡ã«ã¯ã¯é幎ã®å£²äžé«èŠéããåŒãäžãããäžåœã«ãããHPVã¯ã¯ãã³ãã¬ãŒãã·ã«ãã®éèŠæžå°ããã®èŠå ã§ããã
ãã©ãŠã§ã¢å·ãã ã¢ãŒãºã»ãã«ãã¬ã³ãºã»ãã«ã¹ã§å°å ãã©ã€ããªã±ã¢ã®ããŒããåãããžã§ããµã³ã»ãã©ãŒå»åž«ã¯ãAxiosã®åæã«å¯ŸãããCOVIDã®ãã³ãããã¯ãšãã®ææã®æ¿æ²»æ å¢ããã¯ã¯ãã³ã®ä¿¡é Œæ§ãšã¯ã¯ãã³ãžã®ããããã«å€§ããªåœ±é¿ãäžããããšèªã£ãã
Axiosã®å ±åæžã¯ãŸããCOVID-19ã®äºé²æ¥çš®ãæ°å€ãåããRSVã¯ã¯ãã³ãåããŠæ¥çš®ããå¯èœæ§ãããããšãããäžéšã®äººã ã«ãšã£ãŠ ãæ··ä¹±ãã¯ã¯ãã³ç²ã ããããå¯èœæ§ã瀺åããŠããã
ã³ãã³ãã¢å€§åŠã¡ã€ã«ãã³å ¬è¡è¡ç倧åŠé¢ã®å¥åº·æ¿çã»ç®¡çåŠææã§ããã«ã€ã»ã«ã²ãªå士ã¯ãã¯ã¯ãã³æ¥çš®ããããã人ãå¢ããŠããã®ã¯ããããåºç¯ãªäºæ¥µåãšæš©åšãžã®äžä¿¡æãã人ã ãã誀ã£ãæ å ±ãã«èµ°ãããŠããããã ãšææããã
ããããããŒã¯ã¹æ°ã«èšãããã°ãã代æ¿ãšãªãè©å€ã®è¯ãæ å ±æº ããæ±ãã人ã ã®å²åãå¢ããŠããã®ã ãšããã人ã ããã®ãããªæ å ±ãçºèŠããã«ã€ããŠãããŒã¯ã¹æ°ã®æ 床ã¯ããã«å€åããŠããã ããã
圌女ã¯èšãïŒ
ãä¹³å¹Œå æã®è³ã®çºéã«å¿ èŠãªæççç¶æ ãä¿é²ãããããªã©ã€ãã¹ã¿ã€ã«ãéžæããªãããåã©ããã¡ã®ãããã¯ã¹ãšå ç«åã¢ãããèªç¶ã«ãµããŒãããæ¹æ³ããç§ãã¡å šå¡ãç¥ãæä»£ã«ãªãã€ã€ããã®ã§ããã
ãã«ã·ã£ãŒã¯ã人ã ã¯ãæ€é²ã®æ¿ãã颚ã«ãããããããéèŠãªè£œåå®å šæ§ããŒã¿ãçºä¿¡ãç¶ããã¹ãã ããšè¿°ã¹ã誀ã£ãæ å ±ãéé£ããã
ãŸãããèã®æ ¹ã¬ãã«ã§ã®æè²ãç¶ããã¹ãã ããšããŒã¯ã¹æ°ã¯èšãããç¥ã£ãŠãã人ãã¡ã¯ããã®æ ãå§ããã°ããã®äººãã¡ã®æ å ±æºãšãªãããããèªåèªèº«ãæè²ãç¶ããå¿ èŠããããã¿ãã³ã®ç ãäœã«æªãããšã誰ããç¥ã£ãŠããã®ãšåãããã«ãã¯ã¯ãã³ã®åé¡ç¹ã誰ããç¥ãå¿ èŠããããã